中成药
药方
中医药
替代医学
北京
医学
传统医学
家庭医学
中国
药理学
政治学
法学
病理
作者
Rui Jin,Kuijun Zhao,Guo Gui-ming,Bing Zhang,Yuguang Wang,Xue Chun-Miao,Yiheng Yang,Lixia Wang,Guohui Li,Jinfa Tang,Lixing Nie,Xianglin Zhang,Tingting Zhao,Yi Zhang,Can Yan,Yuan Suo-zhong,Lulu Sun,Feng Xing-zhong,Dan Yan
出处
期刊:PubMed
日期:2018-03-01
卷期号:43 (5): 1049-1053
被引量:7
标识
DOI:10.19540/j.cnki.cjcmm.2018.0036
摘要
With the growth of number of Chinese patent medicines and clinical use, the rational use of Chinese medicine is becoming more and more serious. Due to the complexity of Chinese medicine theory and the uncertainty of clinical application, the prescription review of Chinese patent medicine always relied on experience in their respective, leading to the uncontrolled of clinical rational use. According to the traditional Chinese medicine (TCM) theory and characteristics of the unique clinical therapeutics, based on the practice experience and expertise comments, our paper formed the expert consensus on the prescription review of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing. The objective, methods and key points of prescription review of Chinese patent medicine, were included in this expert consensus, in order to regulate the behavior of prescription and promote rational drug use.
科研通智能强力驱动
Strongly Powered by AbleSci AI